Clearside Biomedical Inc. News
Clearside Jumps; Wedbush Triples Target After Eye-Drug Trial Progress
Wedbush raised its price target on Clearside after the company reported progress in a clinical trial of CLS-AX, which treats age-related macular degeneration.
5 Top Stock Gainers for Tuesday: Exxon Mobil, Del Taco, Ocugen
Exxon Mobil, Del Taco Restaurants, Ocugen, Clearside Biomedical and Torchlight Energy Resources are five top gainers for Tuesday.
Clearside Biomedical Soars; Roth Capital Calls Eye Drug 'Game Changer'
Clearside Biomedical rises as a Roth Capital analyst says the company's eye treatment test results are 'a game changer.'
Biotech Premarket Movers: Impax, Clearside Biomedical, Mylan
Impax Laboratories, Clearside Biomedical and Mylan were among the biotech stock movers in premarket trading Wednesday.
Biotech premarket movers: Pacira, Clearside Biomedical and Organovo
Pacira Pharmaceuticals, Clearside Biomedical and Organovo Holdings are among the premarket biotech movers on Wednesday.
Breaking News
Stock Market Today: Stocks Lower As Inflation Worries Resurface; JPMorgan CEO Sees Recession
With inflation still sticky, and global headwinds accelerating, JPMorgan CEO Jamie Dimon now sees a greater chance of a U.S. recession.
"Big Short" Michael Burry Makes a Surprising Decision
The renowned investor wants to end a habit that is part of his legend.
Las Vegas Strip-Adjacent Venue Adding Formerly Forbidden Vice
Something that has never been legal -- even in Sin City -- is coming to a major location just off the Las Vegas Strip.
Meta Stock Tumbles On Report EU Flagging Concern Over Targeted Ad Sales
The Wall Street Journal reported Tuesday that a panel advising the European Data Protection Board has raised concerns over Meta's targeted ad sales.